LONDON--(BUSINESS WIRE)--
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi | |||||||||
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii |
Eco Animal Health plc | ||||||||
2 Reason for the notification (please tick the appropriate box or boxes): | |||||||||
An acquisition or disposal of voting rights |
X |
||||||||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | |||||||||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | |||||||||
An event changing the breakdown of voting rights | |||||||||
Other (please specify): | |||||||||
3. Full name of person(s) subject to the notification obligation: iii |
M&G Investment Funds (3) | ||||||||
4. Full name of shareholder(s) (if different from 3.):iv |
State Street Noms Ltd A/C GMIQ | ||||||||
5. Date of the transaction and date on which the threshold is crossed or reached: v |
09 March 2017 | ||||||||
6. Date on which issuer notified: | 10 March 2017 | ||||||||
7. Threshold(s) that is/are crossed or reached: vi, vii |
See item 13 |
8. Notified details: | |||||||||||||||||||||||||||||||||
A: Voting rights attached to shares viii, ix | |||||||||||||||||||||||||||||||||
Class/type of shares
|
Situation previous to the triggering transaction |
Resulting situation after the triggering transaction | |||||||||||||||||||||||||||||||
Number of Shares |
Number of Voting Rights |
Number of shares |
Number of voting rights |
% of voting rights x | |||||||||||||||||||||||||||||
Direct | Direct xi | Indirect xii | Direct | Indirect | |||||||||||||||||||||||||||||
ORD GBP0.05
GB0032036807 |
7,200,862 | 7,200,862 | 7,163,862 | 0 | 7,163,862 | 0 | 10.95% | ||||||||||||||||||||||||||
B: Qualifying Financial Instruments | |||||||||||||||||||||||||||||||||
Resulting situation after the triggering transaction | |||||||||||||||||||||||||||||||||
Type of financial instrument |
Expiration date xiii |
Exercise/ Conversion Period xiv |
Number of voting rights that may be acquired if the instrument is exercised/ converted. |
% of voting rights |
|||||||||||||||||||||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi | |||||||||||||||||||||||||||||||||
Resulting situation after the triggering transaction | |||||||||||||||||||||||||||||||||
Type of financial instrument |
Exercise price | Expiration date xvii |
Exercise/ Conversion period xviii |
Number of voting rights instrument refers to | % of voting rights xix, xx | ||||||||||||||||||||||||||||
|
Nominal | Delta | |||||||||||||||||||||||||||||||
Total (A+B+C) | |||||||||||||||||||||||||||||||||
Number of voting rights | Percentage of voting rights | ||||||||||||||||||||||||||||||||
7,163,862 | 10.95% |
9. Chain of controlled undertakings through which the voting
rights and/or the financial instruments are effectively held, if applicable: xxi |
|||||
|
|||||
Proxy Voting: | |||||
10. Name of the proxy holder: | N/A | ||||
11. Number of voting rights proxy holder will cease to hold: |
N/A | ||||
12. Date on which proxy holder will cease to hold voting rights: |
N/A | ||||
13. Additional information: |
With reference to item 3, M&G Investments Funds (3) is an Open Ended Investment Company (OEIC) and is not a Prudential group company and must be separately disclosed.
This OEIC Fund is managed by M&G Investment Management Limited (a wholly owned subsidiary of Prudential plc) and will have been previously attributed to Prudential plc solely on the basis that M&G Investment Management Ltd has direct fund management control over the shares identified in this notification.
Therefore the 10.95% holding being disclosed in this notification is encompassed in the 10.95% holding being disclosed under The Prudential plc group of companies and is NOT in addition to it. |
||||
14. Contact name: |
John Baker / Owen Smith / James Todd
M&G Investment Management Limited |
||||
15. Contact telephone number: | 020 7548 2561 / 020 7004 4517 / 020 7548 2293 |